4
Changes in Ownership
PTC THERAPEUTICS, INC. Filed Acc 0001680329-25-000008
Director sold 15,666 shares at $69.50 ($1,088,787)
- Director acquired 12,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Reeve Emma · Director
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-10-30 | Sale : show line 1 in the form 10b5-1 | −3,666 | $69.50 | $254,787 | 6,666 | D |
| 2025-10-30 | Exercise or conversion : show line 2 in the form 10b5-1 | +12,000 | $38.10 | $457,200 | 18,666 | D |
| 2025-10-30 | Sale : show line 3 in the form 10b5-1 | −12,000 | $69.50 | $834,000 | 6,666 | D |
| Open-market sales · 15,666 sh · avg $69.50 · $1,088,787 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-10-30 | Exercise or conversion : show line 4 in the form 10b5-1 Stock Option (Right to Buy) | −12,000 | 0 | D |
Loading xslF345X05/form4-10312025_051001.xml…